Table 1.
Subject demographic characteristics and clinical outcomes.
| iNO |
iEpo |
P value | |||
|---|---|---|---|---|---|
| Number |
Percent | Number |
Percent | ||
| N = 69 | N = 15 | ||||
| Male | 49 | 71.0 | 14 | 93.3 | 0.1 |
| Female | 20 | 29.0 | 1 | 6.7 | 0.1 |
| White | 29 | 42.0 | 3 | 20.0 | 0.08 |
| African american | 8 | 11.6 | 0 | 0 | 0.08 |
| Asian | 4 | 5.8 | 1 | 6.7 | 0.08 |
| Other race | 19 | 27.5 | 8 | 53.3 | 0.08 |
| Unknown | 5 | 7.2 | 3 | 20.0 | 0.08 |
| Latino | 24 | 34.8 | 9 | 60.0 | 0.093 |
| DM | 24 | 34.8 | 3 | 20.0 | 0.22 |
| HTN | 34 | 49.3 | 5 | 33.3 | 0.40 |
| Congestive Heart Failure | 3 | 4.3 | 0 | 0 | 0.45 |
| Chronic Renal Disease | 8 | 11.6 | 1 | 6.7 | 0.28 |
| Liver disease | 6 | 8.7 | 0 | 0.0 | 0.24 |
| Asthma | 7 | 10.1 | 0 | 0.0 | 0.46 |
| HIV | 1 | 1.4 | 1 | 6.7 | 0.33 |
| Cancer | 4 | 5.8 | 0 | 0.0 | 0.36 |
| Organ transplant | 3 | 4.3 | 0 | 0 | 0.54 |
| Tracheostomy | 31 | 44.9 | 2 | 13.3 | 0.039 |
| Mortality day 30 | 36 | 52.2 | 14 | 93.3 | 0.0031 |
| Renal Replacement Therapy | 15 | 21.7 | 7 | 46.7 | 0.58 |
| Median | IQR | Median | IQR | ||
| Age | 62 | 10.0 | 54 | 22.0 | 0.0032 |
| BMI | 30.62 | 10.1 | 30.5 | 7.7 | 0.85 |
| Days Intubation to Inhaled Pulmonary vasodilator | 6 | 11.0 | 7 | 11.0 | 0.40 |
| Inhaled Pulmonary Vasodilator Hours | 106 | 164.0 | 53 | 58.0 | 0.0048 |